Jefferies Group's OLMA Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 11,000 shares of Olema Pharmaceuticals, Inc. (OLMA) worth $137,610, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in OLMA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 4,000 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Olema Pharmaceuticals (OLMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Olema Pharmaceuticals (OLMA) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +4,000 | Add 57.14% | 11,000 | $12.51 |
| Q1 2026 | +4,000 | Add 133.33% | 7,000 | $14.91 |
| Q4 2025 | +3,000 | New Buy | 3,000 | $25.00 |
Jefferies Group's Olema Pharmaceuticals Investment FAQs
Jefferies Group first purchased Olema Pharmaceuticals, Inc. (OLMA) in Q4 2025, acquiring 3,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Olema Pharmaceuticals, Inc. (OLMA) for 3 quarters since Q4 2025.
Jefferies Group's largest addition to Olema Pharmaceuticals, Inc. (OLMA) was in Q1 2026, adding 7,000 shares worth $104,370.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 11,000 shares of Olema Pharmaceuticals, Inc. (OLMA), valued at approximately $137,610.
As of the Q2 2026 filing, Olema Pharmaceuticals, Inc. (OLMA) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Olema Pharmaceuticals, Inc. (OLMA) was 11,000 shares, as reported at the end of Q2 2026.